 |
市場調查報告書
預填充式注射器的全球市場:各材料，應用，類型，地區的成長率，趨勢及預測(2018年∼2023年)Prefilled Syringes Market Size - Growth, Trends, and Forecast (2020-2025) |
||||||
| 出版商 | Mordor Intelligence Pvt Ltd | 商品編碼 | 661176 | ||||
| 出版日期 | 內容資訊 | 英文 114 Pages 商品交期: 2-3個工作天內 |
|||||
| 價格 |
|
||||||
| 預填充式注射器的全球市場:各材料，應用，類型，地區的成長率，趨勢及預測(2018年∼2023年) Prefilled Syringes Market Size - Growth, Trends, and Forecast (2020-2025) | ||
| 出版日期: 2020年08月01日 | 內容資訊: 英文 114 Pages |
|
全球預填充式注射器市場，預計從2018年到2023年的預測期間內，記錄10.5％的成長率。預填充式注射器，與傳統的方法比較，提供更簡單的注射的藥物輸送的方法。這可節約醫護人員的時間和勞力。還有降低活性醫藥成分(API)的浪費。醫護人員為了提高患者的安全性和減少醫院的錯誤的努力，預填充式注射器的的需求也提高。歐洲市場，由於自我護理設備的引進的增加和主要企業的存在，預計佔有率成為市場最大。
本報告提供全球預填充式注射器市場調查，整體市場趨勢，各材料、應用、類型、地區的詳細趨勢，市場成長的影響要素分析，競爭情形，主要企業簡介等，總括性彙整。
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
The market for prefilled syringes is projected to grow, owing to factors, such as increasing adoption of self-care devices, benefits associated with prefilled syringes, and high demand for improved safety in injectables.
The prefilled syringes make injections easy, accurate, and safe for, both, patients and doctors. Pre-filled syringes have emerged as one of the fastest-growing choices for unit dose medication, as the pharmaceutical industry seeks new and more convenient drug delivery methods.
In addition, pharmaceutical companies can get benefit by saving the cost of vials. The prefilled syringes work well with safety devices and auto-injection systems. Pharmaceutical companies are able to minimize drug waste and increase product life span, while patients are able to self-administer injectable drugs at their home instead of the hospital. Pre-filled syringes have also been utilized across a wide range of therapeutic sectors, such as vaccines, blood stimulants, and therapeutic proteins.
Eliminating dosing errors and ease of use are two of the greatest advantages of pre-filled syringes. Consequently, the differential advantages provided by prefilled syringes over traditional syringes are leading to the increased adoption and contributing to the global market growth.
Glass Prefilled Syringes are Projected to Experience Highest Growth Over the Forecast Period
The pharmaceutical industry uses glass syringes manufactured from Type 1 borosilicate glass, which consists primarily of silicon dioxide, along with oxides of boron, aluminum, sodium, and potassium. Metal ions, specifically sodium dioxide, are included in the mixture to alter the physical properties of the glass.
Glass syringes are manufactured from tubing glass. The glass tubing is created by heating the glass mixture to approximately 1500°C and continuously pulling the molten glass along a hollow spindle. Processing conditions, such as speed and airflow, are tightly controlled to prevent failures, such as airlines in the glass, from occurring. While glasses are generally unreactive, they are not necessarily inert. Alkali metals can leach out of glass, resulting in pH shifts in the solution. Some drug molecules are also labile for adsorption to the charged surface of the glass, resulting in decreased potency of the drug solution.
There have been reported instances when tungsten residues in the glass syringe Luer cone left behind during manufacturing have led to aggregation and particle formation in protein solutions. Apart from the above-mentioned challenges of drug interaction, glass prefilled syringes are also prone to breakage.
The market for glass prefilled syringes will grow regardless, albeit very sluggishly in the forecast period, primarily due to increased adoption of prefilled syringes in the developing regions, where glass syringes provide reusability and lower cost.
North America Dominates the Market
On January 22, 2013, the US FDA published the long-anticipated Final Rule: "Current Good Manufacturing Practice Requirements for Combination Products", with the purpose of clarifying regulatory requirements for quality systems used to design, develop, and manufacture combination products, and to help ensure consistent and appropriate application and enforcement of these requirements.
Prefilled drug delivery systems, including prefilled syringes, are combination products subject to the Final Rule. From a manufactures perspective, the Final Rule, as provided by the US FDA, tightens the regulations for syringe manufacturers and has made the manufacturing operation more stringent than before. This has acted as a deterrent to global players based in the United States and prevents them from expanding their regional operations, in other regions.
Overall, there is a large concentration of vendors supplying both end products and original components in the prefilled syringe market. The use of prefilled syringes in the United States is consequently ensured by the presence of appropriate vendors. Lifestyle associated illnesses and growing demand for easy-to-administer injectables in patients of chronic disease are helping the US prefilled syringe market flourish.
The market for prefilled syringes is moderately competitive and there is high price competition in the market. The market is comprised of, both, global and local players. Most of the developing countries are having local players that provide prefilled syringes at a lower price. However, the market is majorly dominated by global companies. Few companies are expected to penetrate the market in the near future and they are expected to account for a substantial share of the prefilled syringes market.
預填充式注射器:全球市場分析·預測
預填充注射器的全球市場：按設計，產品類型，處理類別，應用-2025-COVID-19的累積影響進行的全球預測
預填充注射器：按類型，設計和應用，行業分析，區域前景，應用潛力，競爭性市場份額和預測的市場規模（2021-2027）
預填充式注射器:市場分析，競爭情形，市場預測 (2025年)
預填充注射器的全球市場（∼2025年）：類型（傳統（一次性/可重複使用）/安全）/材料（玻璃/塑料）/設計（單腔/雙腔/定制）/應用（糖尿病/癌症，關節炎等），地區別
全球雙室預充式註射器市場規模調查：按材料，適應，應用，地區進行的預測（2020-2027）
雙腔預裝注射器的全球市場（∼2025年）：材料（玻璃/塑料）/適應症（血液學/精神分裂症/子宮內膜異位/勃起功能障礙/糖尿病）/產品（液體/粉末/液體/液體）□按地區
全球預填充式注射器市場:2020年∼2024年
預填充式注射器的全球市場:各材料，各設計，各類型，各用途，各地區的佔有率，市場規模，趨勢，產業分析:2020年∼2027年
預填充式注射器填充/完工服務市場 (2020∼2030年)
